# ERIBULIN MESYLATE
> **ANDA218743** · Abbreviated New Drug Application (Generic) · Sponsor: CHIA TAI TIANQING · Approved 2025-03-04
## Drug
- **FDA Application Number:** ANDA218743
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ERIBULIN MESYLATE
- **Generic name:** ERIBULIN MESYLATE
- **Active ingredients:** ERIBULIN MESYLATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CHIA TAI TIANQING
- **Manufacturer:** Sun Pharmaceutical Industries Limited
- **First approval:** 2025-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218743)
---
*MORVS · CC0 1.0*